Important Safety Information on CRYSVITA (burosumab) and the… recall
Important Safety Information on CRYSVITA (burosumab) and the Risk of Severe Hypercalcemia in Patients with Tertiary Hyperparathyroidism
- Published
- 25 Aug 2025
- Agency
- Health Canada
- Country
- Canada
The hazard
New safety information - Product safety
What to do
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Source: Health Canada, published 25 Aug 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.